Items where Author is "Eng, Gilbert"

Article

Akahoshi, Yu and Portelli, Joseph and Katsivelos, Nikolaos and Louloudis, Ioannis E. and Aguayo-Hiraldo, Paibel and Ayuk, Francis and Chanswangphuwana, Chantiya and Choe, Hannah K. and Eder, Matthias and Etra, Aaron M. and Hexner, Elizabeth O. and Kitko, Carrie L. and Kraus, Sabrina and Merli, Pietro and Olson, Timothy S. and Pasic, Ivan and Qayed, Muna and Reshef, Ran and Schechter, Tal and Marx, Julia and Ullrich, Evelyn and Vasova, Ingrid and Weber, Daniela and Wolfl, Matthias and Zeiser, Robert and Baez, Janna and Eng, Gilbert and Gleich, Sigrun and Kowalyk, Steven and Morales, George and Spyrou, Nikolaos and Young, Rachel and Defilipp, Zachariah and Hogan, William J. and Nakamura, Ryotaro and Levine, John E. and Ferrara, James L. M. (2025) The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD. BLOOD ADVANCES, 9 (22). pp. 5763-5773. ISSN 2473-9529, 2473-9537

Katsivelos, Nikolaos and Spyrou, Nikolaos and Weber, Daniela and Vasova, Ingrid and Ayuk, Francis and Choe, Hannah and Hogan, William and Defilipp, Zachariah and Qayed, Muna and Etra, Aaron M. and Sandhu, Karam and Kraus, Sabrina and Olson, Tim and Hexner, Elizabeth and Aguayo-Hiraldo, Paibel and Reshef, Ran and Ullrich, Evelyn and Schechter, Tal and Kitko, Carrie and Chanswangphuwana, Chantiya and Merli, Pietro and Akahoshi, Yu and Baez, Janna and Eng, Gilbert and Beheshti, Rahnuma and Kowalyk, Steven and Morales, George and Louloudis, Ioannis Evangelos and Young, Rachel and Holler, Ernst and Nakamura, Ryotaro and Ferrara, James L. M. and Levine, John E. (2025) Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. TRANSPLANTATION AND CELLULAR THERAPY, 31 (1). pp. 100-10000000000. ISSN 2666-6375, 2666-6367

Spyrou, Nikolaos and Akahoshi, Yu and Kowalyk, Steven and Morales, George and Beheshti, Rahnuma and Aguayo-Hiraldo, Paibel and Al Malki, Monzr M. and Ayuk, Francis and Bader, Peter and Baez, Janna and Capellini, Alexandra and Choe, Hannah and Defilipp, Zachariah and Eder, Matthias and Eng, Gilbert and Etra, Aaron and Gleich, Sigrun and Grupp, Stephan A. and Hexner, Elizabeth and Hoepting, Matthias and Hogan, William J. and Kasikis, Stelios and Katsivelos, Nikolaos and Khan, Alina and Kitko, Carrie L. and Kraus, Sabrina and Kwon, Deukwoo and Merli, Pietro and Portelli, Joseph and Qayed, Muna and Reshef, Ran and Schechter, Tal and Vasova, Ingrid and Woefl, Matthias and Wudhikarn, Kitsada and Young, Rachel and Holler, Ernst and Chen, Yi-Bin and Nakamura, Ryotaro and Levine, John E. and Ferrara, James L. M. (2024) A Day 14 Endpoint for Acute GVHD Clinical Trials. TRANSPLANTATION AND CELLULAR THERAPY, 30 (4). pp. 421-432. ISSN 2666-6375, 2666-6367

Rios, Carlos A. Ortega and Qayed, Muna and Etra, Aaron M. and Reshef, Ran and Newcomb, Richard and Yuhasz, Nicholas and Hexner, Elizabeth O. and Aguayo-Hiraldo, Paibel and Merli, Pietro and Hogan, William J. and Weber, Daniela and Kitko, Carrie L. and Ayuk, Francis and Eder, Matthias and Grupp, Stephan A. and Kraus, Sabrina and Sandhu, Karam and Ullrich, Evelyn and Vasova, Ingrid and Woelfl, Matthias and Baez, Janna and Beheshti, Rahnuma and Eng, Gilbert and Gleich, Sigrun and Katsivelos, Nikolaos and Kowalyk, Steven and Louloudis, Ioannis Evangelos and Morales, George and Spyrou, Nikolaos and Young, Rachel and Nakamura, Ryotaro and Levine, John E. and Ferrara, James L. M. and Akahoshi, Yu (2024) Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. TRANSPLANTATION AND CELLULAR THERAPY, 30 (11): 10610. ISSN 2666-6375, 2666-6367

Akahoshi, Yu and Spyrou, Nikolaos and Hoepting, Matthias and Aguayo-Hiraldo, Paibel and Ayuk, Francis and Chanswangphuwana, Chantiya and Choe, Hannah K. and Eder, Matthias and Etra, Aaron M. and Grupp, Stephan A. and Hexner, Elizabeth O. and Hogan, William J. and Kitko, Carrie L. and Kraus, Sabrina and Al Malki, Monzr M. and Merli, Pietro and Qayed, Muna and Reshef, Ran and Schechter, Tal and Ullrich, Evelyn and Vasova, Ingrid and Woelfl, Matthias and Zeiser, Robert and Baez, Janna and Beheshti, Rahnuma and Eng, Gilbert and Gleich, Sigrun and Kasikis, Stelios and Katsivelos, Nikolaos and Kowalyk, Steven and Morales, George and Young, Rachel and DeFilipp, Zachariah and Ferrara, James L. M. and Levine, John E. and Nakamura, Ryotaro (2024) Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. BLOOD ADVANCES, 8 (8). pp. 2047-2057. ISSN 2473-9529, 2473-9537

DeFilipp, Zachariah and Kim, Haesook T. and Spyrou, Nikolaos and Katsivelos, Nikolaos and Kowalyk, Steven and Eng, Gilbert and Kasikis, Stelios and Beheshti, Rahnuma and Baez, Janna and Akahoshi, Yu and Ayuk, Francis and Choe, Hannah and Etra, Aaron and Grupp, Stephan A. and Hexner, Elizabeth O. and Hogan, William J. and Kitko, Carrie L. and Qayed, Muna and Reshef, Ran and Vasova, Ingrid and Zeiser, Robert and Young, Rachel and Holler, Ernst and Ferrara, James L. M. and Nakamura, Ryotaro and Levine, John E. and Chen, Yi-Bin (2024) The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. BLOOD ADVANCES, 8 (13). pp. 3488-3496. ISSN 2473-9529, 2473-9537

Akahoshi, Yu and Spyrou, Nikolaos and Weber, Daniela and Aguayo-Hiraldo, Paibel and Ayuk, Francis and Chanswangphuwana, Chantiya and Choe, Hannah K. and Eder, Matthias and Etra, Aaron M. and Grupp, Stephan A. and Hexner, Elizabeth O. and Hogan, William J. and Kitko, Carrie L. and Kraus, Sabrina and Malki, Monzr M. Al and Merli, Pietro and Qayed, Muna and Reshef, Ran and Schechter, Tal and Ullrich, Evelyn and Vasova, Ingrid and Woelfl, Matthias and Zeiser, Robert and Baez, Janna and Beheshti, Rahnuma and Eng, Gilbert and Gleich, Sigrun and Katsivelos, Nikolaos and Kowalyk, Steven and Morales, George and Young, Rachel and Chen, Yi-Bin and Nakamura, Ryotaro and Levine, John E. and Ferrara, James L. M. (2024) Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. BLOOD, 144 (9). ISSN 0006-4971, 1528-0020

Malki, Monzr M. Al and London, Kaitlyn and Baez, Janna and Akahoshi, Yu and Hogan, William J. and Etra, Aaron and Choe, Hannah and Hexner, Elizabeth and Langston, Amelia and Abhyankar, Sunil and Ponce, Doris M. and Defilipp, Zachariah and Kitko, Carrie L. and Adekola, Kehinde and Reshef, Ran and Ayuk, Francis and Capellini, Alexandra and Chanswangphuwana, Chantiya and Eder, Matthias and Eng, Gilbert and Gandhi, Isha and Grupp, Stephan and Gleich, Sigrun and Holler, Ernst and Javorniczky, Nora Rebeka and Kasikis, Stelios and Kowalyk, Steven and Morales, George and Oezbek, Umut and Roesler, Wolf and Spyrou, Nikolaos and Yanik, Gregory and Young, Rachel and Chen, Yi-Bin and Nakamura, Ryotaro and Ferrara, James L. M. and Levine, John E. (2023) Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. BLOOD ADVANCES, 7 (17). pp. 5189-5198. ISSN 2473-9529, 2473-9537

Conference or Workshop Item

Spyrou, Nikolaos and Akahoshi, Yu and Kowalyk, Steven and Morales, George and Beheshti, Rahnuma and Portelli, Joseph and Kwon, Deukwoo and Capellini, Alexandra and Aguayo-Hiraldo, Paibel and Ayuk, Francis Ayuketang and Bader, Peter and Baez, Janna and Chanswangphuwana, Chantiya and Choe, Hannah and DeFilipp, Zachariah and Eder, Matthias and Eng, Gilbert and Etra, Aaron and Gleich, Sigrun and Grupp, Steve and Hexner, Elizabeth and Hogan, William and Javorniczky, Rebeka and Katsivelos, Nikolaos and Khan, Alina and Kitko, Carrie and Kraus, Sabrina and Merli, Pietro and Qayed, Muna and Reshef, Ran and Rosler, Wolf and Schechter, Tal and Weber, Daniela and Wolfl, Matthias and Young, Rachel and Holler, Ernst and Nakamura, Ryotaro and Chen, Yi-Bin and Levine, John and Ferrara, James (2023) AN EARLY ENDPOINT FOR ACUTE GRAFT VERSUS HOST DISEASE CLINICAL TRIALS. In: 49th Annual Annual Meeting of the European Society for Blood and Marrow Transplantation, 23 - 26 April, 2023, Hybrid Meeting.